Advertisement
Screener

Onconetix, Inc. (ONCO) Interest Expense

2.8 / 5 stars · 68/120 Roast Me

Onconetix, Inc. Interest Expense

Onconetix, Inc. (ONCO) reported Interest Expense of $671.63 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-11.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpense · last filed 2024-04-11

  • Onconetix, Inc. interest expense for the quarter ending 2023-12-31 was $188.53K.
  • Onconetix, Inc. interest expense for the quarter ending 2023-09-30 was $269.10K.
  • Onconetix, Inc. interest expense for the quarter ending 2023-06-30 was $214.00K.
  • Onconetix, Inc. interest expense for the quarter ending 2023-03-31 was $0.00.
  • Onconetix, Inc. interest expense for fiscal 2023 was $671.63K.
Period endInterest Expense 3 monthInterest Expense 6 monthInterest Expense 9 monthInterest Expense 12 month
2023-12-31$188.53K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-11
$457.63K
derived: sum of 2 quarters · filed 2024-04-11
$671.63K
derived: sum of 3 quarters · filed 2024-04-11
$671.63K
10-K · filed 2024-04-11
2023-09-30$269.10K
10-Q · filed 2023-11-17
$483.09K
derived: sum of 2 quarters · filed 2023-11-17
$483.09K
10-Q · filed 2023-11-17
2023-06-30$214.00K
10-Q · filed 2023-10-20
$214.00K
10-Q · filed 2023-10-20
2023-03-31$0.00
derived: 10-K 12 month − 3 quarters · filed 2024-04-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
HCW Biologics Inc. (HCWB)United States$0.004B-6.15
REVELATION BIOSCIENCES, INC. (REVB)United States$0.004B
Aptevo Therapeutics Inc. (APVO)United States$0.003B
Sunshine Biopharma Inc. (SBFM)$0.003B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
Alaunos Therapeutics, Inc. (TCRT)United States$0.003B-1.44
Genprex, Inc. (GNPX)United States$0.003B-0.02
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90